Organ on Chip Market by Offering, Type and Geography

Organ-on-Chip Market to reach $163.1 Million by 2025

enquiry@psmarketresearch.com www.psmarketresearch.com

Organ-on-Chip Market

Global organ-on-chip market size is forecasted to reach $163.1 million by 2025. The growth in the market will be led by the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government grants and funds for research.

The organ-on-chip market has been categorized into product and services, on the basis of offering by the market players. The products are expected to register faster growth in demand, registering a CAGR of 43.8% during the forecast period, due to the advancement in research leading to arrangement of newer organs cells on chips.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market

Organ-on-Chip Market

In terms of type, the organ-on-chip market has been categorized as liveron-chip, lung-on-chip, kidney-on-chip, heart-on-chip, intestine-on-chip, brain-on-chip, and others. Among these, liver-on-chip held the largest share in the global organ-on-chip market, in 2017. The increasing prevalence of chronic liver diseases, and advancement in research for its therapeutic intervention are the key factors for the largest share of the category.

Organ-on-chip products find application in toxicology research, physiological model development, and drug discovery. The application of organ-on-chip for drug discovery is projected to witness fastest growth in demand, registering CAGR of 47.7% during the forecast period. On the basis of end user, the adoption of organ-on-chip by pharmaceutical and biotechnology companies is higher as compared to academic & research institutes, and other end users since a majority of grants and investments for research and development are received by these companies.

Organ-on-Chip Market

The players in organ-on-chip market are launching new and innovative products to enhance their product portfolio. For instance, in July 2017, Hmrel Corporation, launched HuRELviral application. The H¾relviral microliver testing platform sustains hepatitis B virus (HBV) infection in actual human liver cells for over thirty days. This is expected to equip virologists with unprecedented insight into a drug candidate’s potential to cure chronic HBV. Furthermore, in February 2017, InSphero AG introduced the GravityTRAP 384 Microtissue Platform at the Society for Laboratory Automation and Screening (SLAS) 2017 Conference. The GravityTRAP 384 platform features distinct microtissue culture and media chambers separated by a tapered SureXchange pipetting ledge, and a continuous flat-bottomed glass base plate combined with a black-walled body, ensuring superior confocal and high content imaging optics while reducing fluorescent cross-talk between wells.

Organ-on-Chip Market

Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V., TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and Organovo Holdings, Inc. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/sendenquiry?enquiry-url=organ-on-chip-market

Organ-on-Chip Market

Download report sample at:

https://www.psmarketresearch.com/market-analysis/organon-chip-market/report-sample

GET IN TOUCH

THANK YOU!

For information regarding permissions and other queries Kindly write to:

enquiry@psmarketresearch.com

US/Canada Toll-Free: 1-888-778-7886

www.psmarketresearch.com